Abstract:Myc proteins are transcription factors crucial for cell proliferation. They have a C-terminal domain that mediates Max and DNA binding, and an N-terminal disordered region culminating in the transactivation domain (TAD). The TAD participates in many protein-protein interactions, notably with kinases that promote stability (Aurora-A) or degradation (ERK1, GSK3) via the ubiquitin-proteasome system. We probed the structure, dynamics and interactions of N-myc TAD using nuclear magnetic resonance (NMR) spectroscopy following its complete backbone assignment. Chemical shift analysis revealed that N-myc has two regions with clear helical propensity: Trp77-Glu86 and Ala122-Glu132. These regions also have more restricted ps-ns motions than the rest of the TAD, and, along with the phosphodegron, have comparatively high transverse (R2) 15N relaxation rates, indicative of slower timescale dynamics and/or chemical exchange. Collectively these features suggest differential propensities for structure and interaction, either internal or with binding partners, across the TAD. Solution studies on the interaction between N-myc and Aurora-A revealed a previously uncharacterised binding site. The specificity and kinetics of sequential phosphorylation of N-myc by ERK1 and GSK3 were characterised using NMR and resulted in no significant structural changes outside the phosphodegron. When the phosphodegron was doubly phosphorylated, N-myc formed a robust interaction with the Fbxw7-Skp1 complex, but mapping the interaction by NMR suggests a more extensive interface. Our study provides foundational insights into N-myc TAD dynamics and a backbone assignment that will underpin future work on the structure, dynamics, interactions and regulatory post-translational modifications of this key oncoprotein.

Intrinsically Disordered Regions in the Transcription Factor MYC:MAX Modulate DNA Binding via Intramolecular Interactions

MYC Binding Near Transcriptional End Sites Regulates Basal Gene Expression, Read-Through Transcription and Intragenic Contacts

Regulation of chromatin architecture by transcription factor binding

Functional interactions among members of the MAX and MLX transcriptional network during oncogenesis

Differential Effects of the Widely Expressed Dmax Splice Variant of Max on E-Box Vs Initiator Element-Mediated Regulation by C-Myc

Stabilization of the Max Homodimer with a Small Molecule Attenuates Myc-Driven Transcription

Elucidation of the structural determinants responsible for the specific formation of heterodimeric Mxd1/Max b-HLH-LZ and its binding to E-box sequences

Functional analysis and the molecular dissection of zinc-fingers and homeoboxes 1 (ZHX1).

Exploring the dynamics and interactions of the N-myc transactivation domain through solution NMR

Cooperation between bHLH transcription factors and histones for DNA access

Transcriptional regulation by MYC: an emerging new model

Of Myc and Mnt

Exploring the dynamics and interactions of the N-myc transactivation domain through solution nuclear magnetic resonance spectroscopy

MAX inactivation deregulates the MYC network and induces neuroendocrine neoplasia in multiple tissues

Mechanism of Interaction Between the Transactivation Domain of N-MYC and the DNA-Binding Surface of TFIIIC5

The Regulation of Target Genes by Co-occupancy of Transcription Factors, C-Myc and Mxi1 with Max in the Mouse Cell Line

Mnt takes control as key regulator of the myc/max/mxd network

Computational insights into the differentiated binding affinities of Myc, Max, and Omomyc dimers to the E-boxes of DNA

Association with TFIIIC limits MYCN localization in hubs of active promoters and chromatin accumulation of non-phosphorylated RNA Polymerase II

The MYCN oncoprotein is an RNA-binding accessory factor of the nuclear exosome targeting complex